New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
09:15 EDTLIVE, DNDN, GPK, TJX, ICPT, CAB, MRK, IRDM, NVS, CCL, ARX, ODP, DKS, ECYT, CLVS, OPHT, ACXM, URBN, SPLSOn The Fly: Pre-market Movers
HIGHER: Aeroflex (ARX), up 25% after agreeing to be acquired by Cobham for about $1.46B... Clovis (CLVS), up 6.6% after receiving breakthrough therapy designation for CO-1686... Ophthotech (OPHT), up 17.6% after entering into an ex-U.S. licensing, commercialization agreement with Novartis (NVS) for Fovista... Dendreon (DNDN), up 9% after announcing presentation of PROVENGE ProACT, IMPACT studies data... Iridium (IRDM), up 5% after upgraded at Raymond James... Acxiom (ACXM), up 3% after upgraded at Wells Fargo... Carnival (CCL), up 2% following upgrade at Morgan Stanley. DOWN AFTER EARNINGS: Dick's Sporting (DKS), down 15%. Peer Cabelas (CAB) also down 2% after Dick's report... Staples (SPLS), down 10%. Peer Office Depot (ODP) also down 2.6% after Staples' report... Urban Outfitters (URBN), down 4%... TJX (TJX), down 4.7%. ALSO LOWER: Intercept (ICPT), down 5.8% after The Street reported that the company knew of abnormal cholesterol levels in patients taking its liver disease drug obeticholic acid... Graphic Packaging (GPK), down 3% after offering 43.65M shares of common stock for holders... LiveDeal (LIVE), down 15% after entering 10M share common stock distribution agreement... Endocyte (ECYT), down 5% after company and partner Merck (MRK) withdraw CMA for vintafolide in Europe.... Molycorp (MCP), down 2.5% after downgraded at Morgan Stanley.
News For DKS;CAB;SPLS;ODP;ICPT;URBN;ARX;TJX;ACXM;CCL;GPK;OPHT;NVS;DNDN;CLVS;IRDM;LIVE;ECYT;MRK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
November 13, 2014
13:32 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
12:39 EDTDKSDick's Sporting volatility elevated into Q3 and outlook
Subscribe for More Information
11:49 EDTTJXTJX November volatility increases into Q3 and outlook
Subscribe for More Information
10:51 EDTSPLSStaples November volatility elevated into Q3 and outlook
Subscribe for More Information
10:19 EDTURBNUrban Outfitters volatility up into Q3 and holiday sales outlook
Subscribe for More Information
10:16 EDTODPOffice Depot, OfficeMax stores to open at 6pm on Thanksgiving Day
Office Depot and OfficeMax retail stores will be open from 6-9 p.m. local time on Thanksgiving Day, Nov. 27, and will re-open on Black Friday, Nov. 28, at 8 a.m.
10:01 EDTCABOn The Fly: Analyst Initiation Summary
Subscribe for More Information
November 12, 2014
17:30 EDTCLVSClovis announces first patient enrolled in TIGER-1 study
Subscribe for More Information
16:41 EDTCABCabela's initiated with an Outperform at Imperial Capital
Subscribe for More Information
12:00 EDTICPTKOLs say 'remains to be seen' if OCA can get accelerated approval, says Leerink
Subscribe for More Information
11:55 EDTICPTIntercept not part of talks with journals, says Deutsche Bank
Subscribe for More Information
11:17 EDTNVS, MRKLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
10:07 EDTCLVSHigh option volume stocks: DDS FOSL ZTS CMA CLVS CZR
Subscribe for More Information
10:00 EDTDNDNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:30 EDTDNDNDendreon upgraded to Neutral from Sell at Roth Capital
Subscribe for More Information
08:18 EDTNVSUBS to hold a conference
Subscribe for More Information
08:13 EDTMRKBoston Biotech to hold a conference
Subscribe for More Information
07:58 EDTNVSGenVec expects 2014 cash burn between $6M-$7M from Novartis collaboration
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use